Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Blumenthal

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Biochemistry|September 15, 2005
Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivationAntony S Dimitrov, John M Louis, Carole A Bewley, et al.
Biochemistry|June 24, 2004
Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41Stephen A Gallo, G Marius Clore, John M Louis, et al.
Biochemistry|January 31, 2007
Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusionAntony S Dimitrov, Amy Jacobs, Catherine M Finnegan, et al.
Journal of Virology|February 29, 2008
Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicityYossef Raviv, Robert Blumenthal, S Mark Tompkins, et al.
Glycoconjugate Journal|April 20, 2004
The role of glycosphingolipids in HIV signaling, entry and pathogenesisMathias Viard, Isabella Parolini, Satinder S Rawat, et al.
Bioorganic & Medicinal Chemistry|January 28, 2009
Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potencyJi-Hye Kang, Himanshu Garg, Dina M Sigano, et al.
Journal of Virology|September 15, 2005
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tailStéphanie Wyss, Antony S Dimitrov, Frédéric Baribaud, et al.
Critical Reviews in Therapeutic Drug Carrier Systems|April 21, 2010
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicAnu Puri, Kristin Loomis, Brandon Smith, et al.
Retrovirology|December 6, 2006
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusionStephen A Gallo, Jacqueline D Reeves, Himanshu Garg, et al.
Pediatric Nephrology (Berlin, Germany)|July 28, 2005
Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanismPatricio E Ray, Angel A Soler-García, Lian Xu, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Biochemistry|September 15, 2005
Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivationAntony S Dimitrov, John M Louis, Carole A Bewley, et al.
Biochemistry|June 24, 2004
Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41Stephen A Gallo, G Marius Clore, John M Louis, et al.
Biochemistry|January 31, 2007
Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusionAntony S Dimitrov, Amy Jacobs, Catherine M Finnegan, et al.
Journal of Virology|February 29, 2008
Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicityYossef Raviv, Robert Blumenthal, S Mark Tompkins, et al.
Glycoconjugate Journal|April 20, 2004
The role of glycosphingolipids in HIV signaling, entry and pathogenesisMathias Viard, Isabella Parolini, Satinder S Rawat, et al.
Bioorganic & Medicinal Chemistry|January 28, 2009
Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potencyJi-Hye Kang, Himanshu Garg, Dina M Sigano, et al.
Journal of Virology|September 15, 2005
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tailStéphanie Wyss, Antony S Dimitrov, Frédéric Baribaud, et al.
Critical Reviews in Therapeutic Drug Carrier Systems|April 21, 2010
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicAnu Puri, Kristin Loomis, Brandon Smith, et al.
Retrovirology|December 6, 2006
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusionStephen A Gallo, Jacqueline D Reeves, Himanshu Garg, et al.
Pediatric Nephrology (Berlin, Germany)|July 28, 2005
Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanismPatricio E Ray, Angel A Soler-García, Lian Xu, et al.
Pageof 9